Our hospital/clinics are in the process of standardizing smart pump libraries and we wanted to see if other institutions have put investigational drugs into smart pump libraries. It would seem challenging given the frequent updates that would be needed and the unique features of research drugs. Has anyone successfully created and maintained investigational drugs in smart pumps? If so, could you share what types of pumps you have and any challenges/lessons learned?

Are your insulin gtt rates assigned a max rate per policy?
Do you require provider notification if the protocol rate will exceed any predetermined value?
Thanks for your feedback.

Does anyone have a protocol they are using and would be willing to share? We find that patients are admitted for other reasons (for example, deep seated infections) and we don't have a standard approach to treat their withdrawal. Sounds like an excellent resident project!

Do you allow the use of topical tranexamic acid for nosebleeds at your institution? If so, is the medication supplied in such a manner as to prevent erroneous systemic administration?

Hi,
Looking for P&Ps, protocols for ketamine use for pain in ED/ICU; and/or palliative/refractory pain.
anything you can share is appreciated!
Kathleen Black
Kathleen.black@dignityhealth.org

Hi there:

I am working with our RN Q&S colleagues to revise the hospital observational medication audits on the floor (med pass audits).

There was some discussion on the message board about this previously, but did seem not generate a lot of response-- thought I would give it another shot.

Wondering if others had a particular format, checklist, or software for completing these audits?

Please feel free to share any forms or experiences with this.

Thanks,

Paul

What does your infusion pump library look like for medications that have different doses/dose ranges based on indication or organ function? Example: We have Alaris/EPIC integration and we have different vasopressin entries (shock versus GI bleed). We are specifically looking at bivalirudin and the potential use in ECMO. We already have two entries (bivalirudin PCI and bivalirudin PCI with renal dysfunction) and are wondering what strategies others have put into place in order to optimize guardrail limits without overloading the number of entries.

thanks,
Gina

CDC guidelines on pneumococcal vaccination-patients who do not meet age/disease state criteria but receive multiple doses of PPSV23, what could be health implications of this? other than duplicate costs of medication/labor, if there have been cases where a patient has received several doses of PPSV23, once a year repeated in less than 5 yrs.

This might be a little off topic, but... Do any facilities use RFID tags, or something similar, on their infusion pumps so they can find them? We recently purchased 20 PCA modules for our Alaris pumps, and most of them are MIA. It is a ridiculous waste of time and money to not be able to find these pumps when you need them. Any help is appreciated!

We are in the market for a new IV infusion pump and we have a pump fair in August. Does anyone have an assessment tool to rate and compare smart pumps?

I reached out to ISMP and we have started an internal assessment tool as well.